KimKramerMD

Pediatric Hematology & Oncology • New York, NY

Physician

Overview of Dr. Kramer

Dr. Kim Kramer is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and New York-Presbyterian Hospital. She received her medical degree from SUNY Upstate Medical University and has been in practice 28 years. She is one of 95 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at NYC Health + Hospitals / Bellevue who specialize in Pediatric Hematology & Oncology. She has more than 100 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(313) 528-0687

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of RochesterFellowship, Pediatric Hematology/Oncology, 1992 - 1993
University of RochesterResidency, Pediatrics, 1989 - 1992
SUNY Upstate Medical UniversityClass of 1989

Certifications & Licensure

NY State Medical License 1993 - 2026
NC State Medical License 2021 - 2022
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer Start of enrollment: 1997 Apr 01
Completed
Phase 1
Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer Start of enrollment: 2004 Feb 05
Terminated
Phase 1
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Start of enrollment: 2006 Jan 01
Completed
Phase 2
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Start of enrollment: 2015 Sep 01
Active, not recruiting
Phase 4
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Det...
Subhanik Purkayastha, Hrithwik Shalu, David Gutman, Andrei Holodny, Shakeel Modak
Journal of Imaging Informatics in Medicine. 2024-12-01
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Sa...
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, Barbara Spitzer, Carolyn Fein Levy
Pediatric Blood & Cancer. 2024-11-01
Theranostic Intratumoral Convection-Enhanced Delivery ofI-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.
Neeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, Maria Donzelli, Scott M Vietri
Journal of Nuclear Medicine. 2024-09-03

Lectures

Intraventricular radioimmunotherapy targeting B7H3 for CNS malignancies.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Y-mAbs Announces Update on Naxitamab and Omburtamab in NeuroblastomaOctober 16th, 2020
Y-mAbs Announces Positive Omburtamab Clinical DataOctober 28th, 2019
Finding a Cure for Children with CNS NeuroblastomaJuly 22nd, 2019
Join now to see all